The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Consort Medical plc

7 Jan 2020 15:25

 

 
FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
 
 

1

KEY INFORMATION
 
(a) Full name of discloser:MELQART ASSET MANAGEMENT (UK) LTD
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

N/A

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:Consort Medical plc
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:06 January 2020
For an opening position disclosure, state the latest practicable date prior to the disclosure
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?NO
If it is a cash offer or possible cash offer, state “N/A”If YES, specify which:
 

2

POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 
Class of relevant security:10p ordinary
 
InterestsShort positions
 
Number%Number%
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:

1,204,269

2.44%

 
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:

1,204,269

2.44%

 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)Rights to subscribe for new securities (including directors’ and other employee options)
 
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
 
 

3

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)Purchases and sales
 

Class of relevant security

Purchase/sale

Number of securities

Price per unit (GBp)

 
 
 
 
(b)Cash-settled derivative transactions
 
Class of relevant securityProduct descriptionNature of dealingNumber of reference securitiesPrice per unit (GBp)
e.g. CFDe.g. opening/closing a long/short position, increasing/reducing a long/short position

10p ordinary

CFD

Increasing a long position

100,000

1025.00

 
 
(c)Stock-settled derivative transactions (including options)
 
(i)Writing, selling, purchasing or varying
 
Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypeExpiry dateOption money paid/ received per unit
e.g. American, European etc.
 
 
(ii)Exercise
 
Class of relevant securityProduct descriptionExercising/ exercised againstNumber of securitiesExercise price per unit
e.g. call option
 
 
 
(d)Other dealings (including subscribing for new securities)
 
Class of relevant securityNature of dealingDetailsPrice per unit (if applicable)
e.g. subscription, conversion
 
 
 
 

4

OTHER INFORMATION
 
(a)Indemnity and other dealing arrangements
 
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None
 
 
 
(b)Agreements, arrangements or understandings relating to options or derivatives
 
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”
None
 
 
 
(c)Attachments
 
Is a Supplemental Form 8 (Open Positions) attached?NO
 
 
Date of disclosure:07 January 2020
Contact name:J. H. Austin
Telephone number:

020 3826 4492

 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200107005100/en/

Copyright Business Wire 2020

Date   Source Headline
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
16th Jul 20193:49 pmRNSHolding(s) in Company
15th Jul 20197:00 amRNSIncident at the Aesica Cramlington API Facility
13th Jun 20197:00 amRNSFull Year results
29th May 20198:37 amRNSHolding(s) in Company
28th May 201912:50 pmRNSHolding(s) in Company
21st May 20194:30 pmRNSNotice of Results
15th Apr 20199:21 amRNSBlock listing Interim Review
1st Apr 20199:00 amRNSTotal Voting Rights
19th Mar 20199:14 amRNSHolding(s) in Company
7th Feb 20191:28 pmRNSAGM Voting Update - Director Declaration
31st Jan 20197:00 amRNSDEV610: FDA approval for Mylan's generic Advair
15th Jan 20193:03 pmRNSHolding(s) in Company
2nd Jan 20199:07 amRNSTotal Voting Rights
21st Dec 20187:00 amRNSClosure of American Depositary Receipt Programme
20th Dec 20188:56 amRNSHolding(s) in Company
11th Dec 20189:11 amRNSDirector/PDMR Shareholding
7th Dec 20189:16 amRNSHolding(s) in Company
6th Dec 20185:18 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSInterim Results
3rd Dec 20188:47 amRNSTotal Voting Rights
8th Nov 20183:49 pmRNSDirector/PDMR Shareholding
7th Nov 20182:49 pmRNSHolding(s) in Company
6th Nov 201812:30 pmRNSNotice of Results
6th Nov 20187:00 amRNSDirectorate Change
31st Oct 201811:17 amRNSDirector/PDMR Shareholding
15th Oct 20189:17 amRNSBlock listing Interim Review
10th Oct 20182:24 pmRNSDirector/PDMR Shareholding
9th Oct 201810:46 amRNSDirector/PDMR Shareholding
2nd Oct 201812:57 pmRNSDirector/PDMR Shareholding
1st Oct 20189:08 amRNSTotal Voting Rights
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSConsort Signs Development Agreements with Opiant
6th Sep 20183:47 pmRNSDirector/PDMR Shareholding
5th Sep 20184:41 pmRNSResult of AGM
3rd Sep 20188:20 amRNSTotal Voting Rights
23rd Aug 20184:51 pmRNSHolding(s) in Company
22nd Aug 20185:21 pmRNSDirector/PDMR Shareholding
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Aug 20187:00 amRNSDirector/PDMR Shareholding
8th Aug 20182:58 pmRNSForm 8.3 - Consort Medical Plc
7th Aug 20183:20 pmRNSForm 8.3 - Consort Medical plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
6th Aug 20183:11 pmRNSForm 8.3 - Consort Medical PLC
6th Aug 20189:28 amRNSForm 8.3 - Consort Medical plc
3rd Aug 20183:08 pmRNSForm 8.3 - Consort Medical PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.